Establishment Labs Q2 net loss widens on higher expenses

Reuters
Aug 07
<a href="https://laohu8.com/S/ESTA">Establishment Labs</a> <a href="https://laohu8.com/S/QTWO">Q2</a> net loss widens on higher expenses

Overview

  • Establishment Labs Q2 revenue grows 16.3%, beating analyst expectations

  • Net loss for Q2 widens, missing analyst estimates

  • 2025 revenue guidance raised, reflecting strong U.S. sales momentum

Outlook

  • Company raises 2025 revenue guidance to $208 mln-$212 mln

  • Establishment Labs expects positive EBITDA in 2025

  • Company anticipates cash flow positive status by 2026

  • Establishment Labs sees U.S. sales momentum continuing into third quarter

Result Drivers

  • US SALES MOMENTUM - Strong U.S. sales of Motiva products contributed $10.3 mln to Q2 revenue, driving overall growth

  • GEOGRAPHIC MIX - Improved gross margin to 68.8% attributed to favorable geographic mix and higher average selling prices

  • SG&A EXPENSES - Increased SG&A expenses due to U.S. investments in personnel and marketing led to wider operating losses

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$51.30 mln

$51 mln (8 Analysts)

Q2 EPS

Miss

-$0.57

-$0.53 (8 Analysts)

Q2 Net Income

Miss

-$16.59 mln

-$15.90 mln (8 Analysts)

Q2 Income From Operations

Miss

-$14.11 mln

-$10.60 mln (8 Analysts)

Q2 Gross Profit

$35.27 mln

Q2 Pretax Profit

-$15.59 mln

Press Release: ID:nBw8sQ8nKa

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10